226 related articles for article (PubMed ID: 31785798)
1. Guideline No. 390-Classification and Management of Endometrial Hyperplasia.
Auclair MH; Yong PJ; Salvador S; Thurston J; Colgan TTJ; Sebastianelli A
J Obstet Gynaecol Can; 2019 Dec; 41(12):1789-1800. PubMed ID: 31785798
[TBL] [Abstract][Full Text] [Related]
2. No. 370-Management of Squamous Cell Cancer of the Vulva.
Francis JA; Eiriksson L; Dean E; Sebastianelli A; Bahoric B; Salvador S
J Obstet Gynaecol Can; 2019 Jan; 41(1):89-101. PubMed ID: 30580832
[TBL] [Abstract][Full Text] [Related]
3. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
Salvador S; Scott S; Francis JA; Agrawal A; Giede C
J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
[TBL] [Abstract][Full Text] [Related]
4. No. 385-Indications for Pelvic Examination.
Evans D; Goldstein S; Loewy A; Altman AD
J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
[TBL] [Abstract][Full Text] [Related]
5. Guideline No. 403: Initial Investigation and Management of Adnexal Masses.
Salvador S; Scott S; Glanc P; Eiriksson L; Jang JH; Sebastianelli A; Dean E
J Obstet Gynaecol Can; 2020 Aug; 42(8):1021-1029.e3. PubMed ID: 32736853
[TBL] [Abstract][Full Text] [Related]
6. Guideline No. 408: Management of Gestational Trophoblastic Diseases.
Eiriksson L; Dean E; Sebastianelli A; Salvador S; Comeau R; Jang JH; Bouchard-Fortier G; Osborne R; Sauthier P
J Obstet Gynaecol Can; 2021 Jan; 43(1):91-105.e1. PubMed ID: 33384141
[TBL] [Abstract][Full Text] [Related]
7. No. 351-Transvaginal Mesh Procedures for Pelvic Organ Prolapse.
Larouche M; Geoffrion R; Walter JE
J Obstet Gynaecol Can; 2017 Nov; 39(11):1085-1097. PubMed ID: 29080723
[TBL] [Abstract][Full Text] [Related]
8. No. 377-Hysterectomy for Benign Gynaecologic Indications.
Thurston J; Murji A; Scattolon S; Wolfman W; Kives S; Sanders A; Leyland N
J Obstet Gynaecol Can; 2019 Apr; 41(4):543-557. PubMed ID: 30879487
[TBL] [Abstract][Full Text] [Related]
9. No. 366-Gynaecologic Management of Hereditary Breast and Ovarian Cancer.
Jacobson M; Bernardini M; Sobel ML; Kim RH; McCuaig J; Allen L
J Obstet Gynaecol Can; 2018 Nov; 40(11):1497-1510. PubMed ID: 30473125
[TBL] [Abstract][Full Text] [Related]
10. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Dominick S; Hickey M; Chin J; Su HI
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
[TBL] [Abstract][Full Text] [Related]
11. Guideline No. 386-Gynaecologic Surgery in the Obese Patient.
Yong PJ; Thurston J; Singh SS; Allaire C
J Obstet Gynaecol Can; 2019 Sep; 41(9):1356-1370.e7. PubMed ID: 31443850
[TBL] [Abstract][Full Text] [Related]
12. Guideline No. 447: Diagnosis and Management of Endometrial Polyps.
Bougie O; Randle E; Thurston J; Magee B; Warshafsky C; Rittenberg D
J Obstet Gynaecol Can; 2024 Mar; 46(3):102402. PubMed ID: 38325734
[TBL] [Abstract][Full Text] [Related]
13. Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials.
Abu Hashim H; Ghayaty E; El Rakhawy M
Am J Obstet Gynecol; 2015 Oct; 213(4):469-78. PubMed ID: 25797236
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
[TBL] [Abstract][Full Text] [Related]
15. Guideline No. 437: Diagnosis and Management of Adenomyosis.
Dason ES; Maxim M; Sanders A; Papillon-Smith J; Ng D; Chan C; Sobel M
J Obstet Gynaecol Can; 2023 Jun; 45(6):417-429.e1. PubMed ID: 37244746
[TBL] [Abstract][Full Text] [Related]
16. Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up.
Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK
Hum Reprod; 2013 May; 28(5):1231-6. PubMed ID: 23466671
[TBL] [Abstract][Full Text] [Related]
17. The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review.
Buttini MJ; Jordan SJ; Webb PM
Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):316-22. PubMed ID: 19566568
[TBL] [Abstract][Full Text] [Related]
18. LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study.
Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK
Hum Reprod; 2013 Nov; 28(11):2966-71. PubMed ID: 23975691
[TBL] [Abstract][Full Text] [Related]
19. No. 369-Management of Pregnancy Subsequent to Stillbirth.
Ladhani NNN; Fockler ME; Stephens L; Barrett JFR; Heazell AEP
J Obstet Gynaecol Can; 2018 Dec; 40(12):1669-1683. PubMed ID: 30527075
[TBL] [Abstract][Full Text] [Related]
20. No. 347-Obstetric Management at Borderline Viability.
Ladhani NNN; Chari RS; Dunn MS; Jones G; Shah P; Barrett JFR
J Obstet Gynaecol Can; 2017 Sep; 39(9):781-791. PubMed ID: 28859764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
